CareDx Announces Transplant Community Secures Win Reaffirming Longstanding Medicare Coverage for AlloSure and AlloMap TestingBusiness Wire • 08/16/24
CareDx (CDNA) Upgraded to Strong Buy: What Does It Mean for the Stock?Zacks Investment Research • 08/07/24
Compared to Estimates, CareDx (CDNA) Q2 Earnings: A Look at Key MetricsZacks Investment Research • 08/01/24
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of CareDx, Inc. (NASDAQ: CDNA)PRNewsWire • 07/16/24
Landmark Independent Publication in Nature Medicine Validates CareDx AlloView AI-Enabled Risk Prediction Model and Demonstrates AlloSure Kidney Detects Subclinical Rejection in Stable PatientsBusiness Wire • 06/03/24
AI Integration and Real-World Utility of CareDx Portfolio Highlighted in New Data at the 2024 American Transplant CongressBusiness Wire • 05/30/24
CareDx Reiterates Position that it Does Not Infringe the ‘544 Patent, Injunction Motion is IrrelevantBusiness Wire • 05/29/24
Landmark Study Shows CareDx's HeartCare Outperforms dd-cfDNA Alone in Identifying Rejection and Patients Experienced Excellent Outcomes with Fewer BiopsiesBusiness Wire • 05/16/24
CareDx (CDNA) Q1 Earnings: Taking a Look at Key Metrics Versus EstimatesZacks Investment Research • 05/10/24
CareDx (CDNA) Q1 Earnings Preview: What You Should Know Beyond the Headline EstimatesZacks Investment Research • 05/07/24
CareDx Appoints John W. Hanna as its New President and Chief Executive OfficerBusiness Wire • 04/16/24
CareDx and Collaborators Present Latest Cardiothoracic Advancements at the 2024 International Society for Heart and Lung Transplantation MeetingBusiness Wire • 04/09/24